AKKARAJU SRINIVAS 4
4 · Kalaris Therapeutics, Inc. · Filed Feb 17, 2026
Research Summary
AI-generated summary of this filing
Kalaris (KLRS) 10% Owner Akkaraju Srinivas Buys $5.0M Stock
What Happened
- Akkaraju Srinivas, reported as a 10% owner of Kalaris Therapeutics (KLRS), purchased 479,847 shares in a privately negotiated transaction on December 18, 2025. The shares were acquired at $10.42 per share for a total reported value of $5,000,006. This was a purchase (code P), which is generally viewed as a more informative signal than routine sales.
Key Details
- Transaction date and price: 12/18/2025 — 479,847 shares @ $10.42 each.
- Total value: $5,000,006.
- Shares held after transaction: The filing notes aggregate holdings in footnote (2) and references an amended prior Form 4 (Dec 22, 2025). The Form 4 does not list a single consolidated total in the main table; see footnotes for details on related fund holdings.
- Notable footnotes:
- F1: Shares were purchased from Samsara BioCapital, L.P. in a privately negotiated sale.
- F3–F5: Several related entities (Samsara Opportunity Fund, Samsara LP, and related GPs) hold shares; Srinivas is a managing member/has voting and investment power over some fund-held shares but disclaims beneficial ownership except to the extent of his pecuniary interest.
- F2: The filing amends a prior Form 4 (Dec 22, 2025) and incorporates those reported purchases.
- Filing timeliness: The Form 4 was filed on 2026-02-17 for a 2025-12-18 transaction; the filing is marked late (L).
Context
- This was a private purchase between related investment entities (Samsara-affiliated funds), not an open-market buy. For insiders and 10% owners, holdings can reflect institutional arrangements and fund-level ownership; footnotes indicate transfers among affiliated funds and disclaimers of beneficial ownership except for pecuniary interest. Purchases like this can be more meaningful than routine sales, but the transaction’s private, fund-related nature and the ownership disclaimers are important for interpreting how much of the purchase reflects Srinivas’s direct economic interest.
Insider Transaction Report
Form 4
AKKARAJU SRINIVAS
Director10% Owner
Transactions
- Purchase
Common Stock
[F1][F2][F3]2025-12-18$10.42/sh+479,847$5,000,006→ 1,979,847 total(indirect: By Samsara Opportunity Fund, L.P.)
Holdings
- 10,968,234(indirect: By Samsara BioCapital, L.P.)
Common Stock
[F4][F5]
Footnotes (5)
- [F1]Represents the purchase of shares from Samsara BioCapital, L.P. ("Samsara LP") in a privately negotiated transaction.
- [F2]Represents the number of shares held as of the date of this filing, including the shares purchased by Samsara Opportunity Fund, L.P. ("Samsara Opportunity Fund") on December 22, 2025, as reported in the reporting persons' Form 4 filed with the SEC on December 22, 2025 (the "Prior Report"). The Prior Report is deemed amended hereby.
- [F3]Securities are directly held by Samsara Opportunity Fund. Samsara Opportunity Fund GP, LLC ("Samsara Opportunity GP") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.
- [F4]The shares held by Samsara LP reflects the disposition of 479,847 shares, to Samsara Opportunity Fund as described in footnote (1), in which the Reporting Person had no pecuniary interest. The transfer of such shares by Samsara LP did not involve a change in the Reporting Person's beneficial ownership of such shares and, accordingly, was exempt from reporting under Section 16.
- [F5]Shares held by Samsara LP. The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara LP. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.